RFS
SRNE

Rockefeller Financial Services’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Rockefeller Financial Services’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-50,512
Closed -$341K – 604
2014
Q2 		$341K Buy
+50,512
New +$381K 0.01% 295

Other funds holding SRNE

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return
B
Baird Milwaukee, Wisconsin $9.78B AUM 11.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

Rockefeller Financial Services's SRNE Position: Q3 2014 in Review

Rockefeller Financial Services sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2014, closing a stake of 50,512 shares — an estimated $341K sold.

Rockefeller Financial Services first reported a position in SRNE in Q2 2014 and held it in 1 quarter. The position peaked at $341K in Q2 2014. 33 funds tracked by Wall St. Rank hold SRNE as of Q3 2014.

  • Rockefeller Financial Services reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
  • Rockefeller Financial Services sold 50,512 Sorrento Therapeutics, Inc. shares in Q3 2014, an estimated $341K.
  • Rockefeller Financial Services first reported a position in Sorrento Therapeutics, Inc. in Q2 2014 and held it in 1 quarter.
  • Rockefeller Financial Services's Sorrento Therapeutics, Inc. position peaked at $341K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2014.

Based on Rockefeller Financial Services's 13F filing for Q3 2014, filed 5 Nov 2014.